Academic Journal
Q1Cancers
About Cancers
Cancers is a scholarly journal published by Multidisciplinary Digital Publishing Institute (MDPI). SCImago 2025 places it in Q1 with an SJR of 1.41 and an H-index of 182.
Its listed coverage is 2009-2026 and its research categories include Oncology (Q1); Cancer Research (Q2). The 2025 dataset reports 4009 documents and 83363 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Pancreatic and Hepatic Oncology Research, Radiomics and Machine Learning in Medical Imaging, Glioma Diagnosis and Treatment.
Recent Research Articles
Latest publications matched automatically by ISSN.
Distinct Alpha-Fetoprotein Trajectories Preceding Hepatocellular Carcinoma Diagnosis: A Latent Class Mixed-Model Analysis
Apichat Kaewdech, Chanavee Toh, Pimsiri Sripongpun, Naichaya Chamroonkul et al.
2026-09-08 · DOI: 10.3390/cancers18182900A Comparison of Outcomes in Patients with Secondary Acute Promyelocytic Leukemia (APL) and De Novo APL—A Case-Matched Retrospective Analysis of the Polish Adult Leukemia Group (PALG)
Agnieszka Pluta, Damian Mikulski, Marta Sobas, Kinga Strzałka et al.
2026-09-08 · DOI: 10.3390/cancers18182899The Impact of Nanoparticles on Proton Therapy: A Review Study
Georgios Nikiforos Ntoumas, Dimitra Desse, Anna Zygogianni, Andromachi Kougioumtzopoulou et al.
2026-09-08 · DOI: 10.3390/cancers18182904Clinical Outcomes and Prognostic Factors in Uterine Adenosarcoma: A Multicenter Retrospective Cohort Study
Atacem Mert Aytekin, Ipek Betul Ozcivit Erkan, Seyma Okumus, Bilgehan Saglik et al.
2026-09-08 · DOI: 10.3390/cancers18182903Pathology-Guided Transcriptomic Profiling of Prostate Cancer Identifies Grade-Associated Proliferative and Immune Signatures in a MENA Cohort
Ranyah Al-Hakm, Alaa Muayad Altaie, Reem Sami Alhamidi, Anania Boghossian et al.
2026-09-08 · DOI: 10.3390/cancers18182898Prognostic Value of Subependymal Enhancement on Baseline MRI in Primary Central Nervous System Lymphoma
Dongsub Kim, Dong-Sup Chung, Wan-Soo Yoon
2026-09-08 · DOI: 10.3390/cancers18182906Recurrence Pattern and Prognostic Value of Major Pathological Response in Patients with Locally Advanced Oesophageal Squamous Cell Carcinoma Treated with Neoadjuvant Immunochemotherapy: A Multicentre Retrospective Study
Feng Wang, Xiangyang Yu, Hao Chen, Dongjie Yan et al.
2026-09-08 · DOI: 10.3390/cancers18182902The Value of Adjuvant Radiotherapy in the Treatment of Melanoma: A Multi-Center Analysis
Magdalena Fischer, Sabine Gerum, Falk Roeder, Matthias Brandlmaier et al.
2026-09-08 · DOI: 10.3390/cancers18182901Baseline Systemic Inflammation Response Index and Clinical Outcomes in Heavily Pretreated Platinum-Resistant Ovarian Cancer Treated with Pembrolizumab Monotherapy
Seongyun Lim, Yurimi Lee, Heeeun Ha, Young Eun Chung et al.
2026-09-08 · DOI: 10.3390/cancers18182905On-Treatment NLR Dynamics During CDK4/6 Inhibition Are Associated with Overall Survival in Metastatic Breast Cancer
Baha Sharaf, Zaid Omari, Qasem Alzoubi, Anas Zayed et al.
2026-09-07 · DOI: 10.3390/cancers18172894Role of Second-Look Ureterorenoscopy After Endoscopic Treatment of Upper Tract Urothelial Carcinoma
Mohammad Abufaraj, Beat Foerster, Tim Muilwijk, Gautier Marcq et al.
2026-09-07 · DOI: 10.3390/cancers18172893Predictive Value of the ALBI Grade for Short-Term Morbidity and Mortality After Pancreatoduodenectomy
Ali Ramouz, Abdulelah Al-Ahdal, Carl-Stephan Leonhardt, Georgios Polychronidis et al.
2026-09-07 · DOI: 10.3390/cancers18172897Evolving Clinicopathological Characteristics of Women with Locally Advanced Cervical Cancer Treated with Definitive Chemoradiation Before and After Implementation of Organized Cervical Cancer Screening in Serbia
Jelena Stanić, Marija Popović-Vuković, Predrag Nikić, Ivana Šović et al.
2026-09-07 · DOI: 10.3390/cancers18172891When Cancer Research Met Artificial Intelligence: From Machine Learning to Intelligent Oncology
Daniele Giansanti
2026-09-07 · DOI: 10.3390/cancers18172896The MAZ-POLD1 Signaling Axis Drives Cisplatin Resistance in Bladder Cancer by Activating DNA Damage Repair
Biao Zhang, Hong Chang, Cheng Wang, Wei Chang et al.
2026-09-07 · DOI: 10.3390/cancers18172892Focused Ultrasound Therapies for Brain, Liver, Prostate, and Breast Cancer Applications: Clinical Evidence and Future Directions
Nassib Abou Heidar, Daniel Sheeran, Divine Nwafor, Olivia C. Sears et al.
2026-09-07 · DOI: 10.3390/cancers18172890The Immune Landscape of Chondrosarcoma: A Review of Tumor-Related Immune Cells
Maria T. Silvaggio, Christian P. Tabler, Sila Basbay, Kurt Weiss et al.
2026-09-07 · DOI: 10.3390/cancers18172889Radiotherapy in Combination with CD20×CD3 Bispecific Antibodies for B-Cell Lymphoma: Biological Rationale, Current Evidence, and Open Questions
Patrizia Ciammella, Alberto Bavieri, Maria Elena Nizzoli, Emanuele Alì et al.
2026-09-07 · DOI: 10.3390/cancers18172895Low Rates of Discontinuation Unrelated to Disease Progression with Trastuzumab Deruxtecan in Metastatic Breast Cancer: A Real-World Study
Luca Licata, Francesca Patanè, Alessandra Guarino, Barbara Galbardi et al.
2026-09-06 · DOI: 10.3390/cancers18172882Long-Term Offspring Outcomes Following Parental Exposure to BCR::ABL1 Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Retrospective Cohort Study with Follow-Up to 24.6 Years
Sándor Pál, Margit Solymár, Hussain Alizadeh
2026-09-06 · DOI: 10.3390/cancers18172885Reviews
Community Reviews
Version History
September 8, 2026 at 12:02 am
September 8, 2026